ISDA

Deposition Date 2007-05-24

Release Date 2007-07-17

Last Version Date 2024-02-21

Entry Detail

PDB ID:

2Q1L

Keywords:

OXIDOREDUCTASE

Title:

Design and Synthesis of Pyrrole-based, Hepatoselective HMG-CoA Reductase Inhibitors

Biological Source:

Source Organism:

Homo sapiens (Taxon ID: 9606)

Host Organism:

Escherichia coli

Method Details:

Experimental Method:

X-RAY DIFFRACTION

Resolution:

2.05 Å

R-Value Free:

0.26

R-Value Work:

0.22

R-Value Observed:

0.22

Space Group:

P 1 21 1

Download Validation Report

Macromolecular Entities

Protein Blast

Polymer Type:polypeptide(L)
Molecule:3-hydroxy-3-methylglutaryl-coenzyme A reductase
Gene (Uniprot):HMGCR
Mutations:M485I
Chain IDs:A, B, C, D
Chain Length:441
Number of Molecules:4
Biological Source:Homo sapiens

UniProt ID:P04035 Pfam ID:PF00368 EC:1.1.1.34

Ligand Molecules

882

Primary Citation

Design and synthesis of hepatoselective, pyrrole-based HMG-CoA reductase inhibitors.

Pfefferkorn, J.A, Song, Y, Sun, K.L, Miller, S.R, Trivedi, B.K, Choi, C, Sorenson, R.J, Bratton, L.D, Unangst, P.C, Larsen, S.D, Poel, T.J, Cheng, X.M, Lee, C, Erasga, N, Auerbach, B, Askew, V, Dillon, L, Hanselman, J.C, Lin, Z, Lu, G, Robertson, A, Olsen, K, Mertz, T, Sekerke, C, Pavlovsky, A, Harris, M.S, Bainbridge, G, Caspers, N, Chen, H, Eberstadt, M.Show

Bioorg.Med.Chem.Lett. 17 4538 4544 (2007)

PMID: 17574412 DOI: 10.1016/j.bmcl.2007.05.096

Abstact

This manuscript describes the design and synthesis of a series of pyrrole-based inhibitors of HMG-CoA reductase for the treatment of hypercholesterolemia. Analogs were optimized using structure-based design and physical property considerations resulting in the identification of 44, a hepatoselective HMG-CoA reductase inhibitor with excellent acute and chronic efficacy in a pre-clinical animal models.

Legend

Protein

Chemical

Disease

Primary Citation of related structures